China's vaccine "warehousing" promotes equitable distribution of vaccines

  The Global Alliance for Vaccines and Immunization (GAVI) issued a press bulletin on the 12th, announcing that it has signed pre-purchase agreements with Sinopharm Group and Kexing. This means that Sinopharm vaccine and Kexing vaccine have entered the "New Coronary Pneumonia Vaccine Implementation Plan" (COVAX) vaccine It can also supply vaccines to COVAX from July for the prevention and control of the new crown epidemic in developing countries.

  This is the first time that a vaccine from a developing country has entered the COVAX vaccine library, which has positive practical significance for the world and China.

The "stocking" of Chinese vaccines is conducive to alleviating the imbalance in the distribution and use of global vaccines.

The Director-General of the World Health Organization Tan Desai has repeatedly stated that there is a serious tendency to "vaccine nationalism" in the world. Some developed countries stock up more vaccines than their citizens need, and some developing countries cannot even work for their health. And the most vulnerable groups to provide basic protection.

The entry of two Chinese vaccines into the COVAX vaccine library can effectively alleviate this dilemma.

  The “stocking” of Chinese vaccines is conducive to WHO and the Global Alliance for Vaccines and Immunization in organizing the global fight against the epidemic.

The mutation rate of the new coronavirus is very fast, and the control of the epidemic is to make the vaccination rate exceed the rate of virus mutation.

The global target set by the WHO is to vaccinate at least 10% of the population in each country by September. The vaccination rate will reach at least 40% by the end of this year and 70% by the middle of next year.

To achieve these goals, it is necessary to accelerate the supply and vaccination.

  After the Sinopharm and Kexing vaccines have received more international recognition, more Chinese vaccine manufacturers will be more confident to apply for WHO emergency use certification and be selected into the vaccine library of the "New Coronary Pneumonia Vaccine Implementation Plan" so that they can share All parties work together to promote the fair distribution of vaccines and make positive contributions to global solidarity in the fight against the epidemic.

  The "stocking" of China's vaccines is an important manifestation of China's practical actions to fulfill its commitment to vaccines as a "global public product".

Since the outbreak of the new crown epidemic, China has been the first to put forward and actively implement the promise of vaccines as a "global public product."

China has promised to provide COVAX with 110 million doses of the new crown vaccine by the end of October this year. The follow-up long-term supply is an important manifestation of the responsibility of major countries.

According to Xinhua News Agency